Investigator
Ca Foscari University Of Venice
Palladium(0) and Juglone: a new alliance in the fight against ovarian cancer
Four Juglone-based Pd(0) complexes with varied ligands were synthesized and characterized. They showed strong cytotoxicity and cancer selectivity. The most promising complex inhibited the PIN1 oncoprotein, as confirmed by Western Blot.
Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy
High-Grade Serous Ovarian Cancer (HGSOC) is the most common and lethal subtype of ovarian cancer, known for its high aggressiveness and extensive genomic alterations.
